T2 Protect AD: Achieving a rapid recruitment timeline in a multisite clinical trial for individuals with mild to moderate Alzheimer's disease.

Aladdin H ShadyabAndrea Z LaCroixGenevieve MatthewsDaniel BennettAlexandre A ShadyabDonna TanRonald G ThomasJennifer MasonAlex LopezBrianna AskewLia DonahueStephen KaplitaIrfan A QureshiBranko HuisaHoward H Feldmannull null

Published in: Alzheimer's & dementia (New York, N. Y.) (2022)

The rapid recruitment of participants with mild to moderate AD was achieved through a range of approaches with varying success.

Keyphrases

clinical trial
loop mediated isothermal amplification
cognitive decline
open label
randomized controlled trial
phase ii
study protocol
phase iii
sensitive detection